Experimental Hematology

• 

  Publication Venue For

  • Spliceosomal component Sf3b1 is essential for hematopoietic differentiation in zebrafish..  44:826-837.e4. 2016
  • Proteomic analysis of murine bone marrow niche microenvironment identifies thioredoxin as a novel agent for radioprotection and for enhancing donor cell reconstitution.  41:944-956. 2013
  • Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL–positive CML cells.  39:66-76.e2. 2011
  • Leukocyte telomere dynamics and human hematopoietic stem cell kinetics during somatic growth..  37:514-524. 2009
  • Costimulation molecule expression and subset distribution of blood dendritic cells in normal children and newly diagnosed pediatric leukemia and lymphoma patients..  36:1691-1703. 2008
  • Accidental or intentional exposure to ionizing radiation: biodosimetry and treatment options..  35:24-27. 2007
  • Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells..  33:308-317. 2005
  • Human platelets exhibit chemotaxis using functional N-formyl peptide receptors..  33:73-84. 2005
  • Platelets deliver costimulatory signals to antigen-presenting cells: a potential bridge between injury and immune activation..  32:135-139. 2004
  • Growth hormone accelerates immune recovery following allogeneic T-cell-depleted bone marrow transplantation in mice..  31:953-958. 2003
  • Coexistent naïve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood..  31:708-714. 2003
  • Vasoactive intestinal peptide (VIP) inhibits the proliferation of bone marrow progenitors through the VPAC1 receptor..  30:1001-1009. 2002
  • Thawed Umbilical Cord Blood (UCB) followed by ex vivo engineering with anti-CD3, IL-2, IL-7 & IL-12 followed by recryopreservation significantly expands and activates UCB cytotoxic lymphocytes (CTLs): Potential for UCB: donor lymphocyte infusion (DLI) post UCB transplantation.  30:137-137. 2002
  • Ex vivo expansion, maturation, and activation of umbilical cord blood-derived T lymphocytes with IL-2, IL-12, anti-CD3, and IL-7. Potential for adoptive cellular immunotherapy post-umbilical cord blood transplantation..  30:245-251. 2002
  • Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes..  29:1403-1409. 2001
  • Acute graft-vs-host disease: pathobiology and management..  29:259-277. 2001
  • Erratum - Acute graft-vs-host disease: Pathobiology and management (Experimental Hematology (2001) 29 (259-277)).  29:653. 2001
  • Granulocyte colony-stimulating factor mobilized peripheral blood stem cells enter into G1 of the cell cycle and express higher levels of amphotropic retrovirus receptor mRNA..  27:1160-1167. 1999
  • A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation..  27:63-74. 1999
  • Analysis of erythropoietin and erythropoietin receptor genes expression in cattle during acute infection with Trypanosoma congolense..  27:37-45. 1999
  • Hl.a-c disparity between patients and unrelated donors (urd) matched for hla-a, -b, and -drb1 alleles by dna typing.  26:691. 1998
  • Multiparameter-fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells..  26:288-298. 1998
  • Combination of rhIL-11 + G-CSF enhances platelet (PLT) and myeloid recovery following ifosfamide, carboplatin, and etoposdde (ICE) chemotherapy in children with solid tumors (ST): RML-11 is well tolerated at double the adult recommended dose.  25:786. 1997
  • A functional tethered ligand thrombin receptor is present on human hematopoietic progenitor cells..  24:914-918. 1996
  • Erythroid AP-1/NF-E2 elements vary in their response to NF-E2..  24:445-452. 1996
  • Does thalidomide affect IL-2 response and production?.  23:978-985. 1995
  • UMBILICAL-CORD BLOOD - AN ALTERNATIVE SOURCE OF HEMATOPOIETIC STEM-CELLS FOR BONE-MARROW RECONSTITUTION IN UNRELATED DONOR TRANSPLANTATION.  23:942-942. 1995
  • Enhancement of human hematopoiesis by mast cell growth factor in human-sheep chimeras created by the in utero transplantation of human fetal hematopoietic cells..  23:252-257. 1995
  • Erratum: Does thalidomide affect IL-2 response and production? (Experimental Hematology, 23, 9 (1995), 978-987).  23:1324. 1995
  • Microcytic anemia in mk/mk mice is not corrected by retroviral-mediated gene transfer of wild-type p45 NF-E2..  23:74-80. 1995
  • The c-kit proto-oncogene receptor is expressed on a subset of human CD3-CD4-CD8- (triple-negative) thymocytes..  22:1025-1033. 1994
  • ALTERNATIVE TRANSPLANTATION OF UMBILICAL-CORD BLOOD-CELLS IN PEDIATRIC-PATIENTS.  22:689-689. 1994
  • CORD-BLOOD TRANSPLANTATION - AN UPDATE.  22:677-677. 1994
  • LISOFYLLINE, A PHOSPHOLIPID SIGNALING INHIBITOR APPEARS TO ACCELERATE TRILINEAGE ENGRAFTMENT FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION.  22:697-697. 1994
  • Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model..  20:1048-1054. 1992
  • DETECTION OF THE KIT PROTOONCOGENE RECEPTOR ON HUMAN HEMATOPOIETIC PROGENITOR CELLS USING THE MONOCLONAL-ANTIBODY 9B9.  20:111-111. 1992
  • Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow..  18:1193-1198. 1990
  • Differential toxicity of carbovir and AZT to human bone marrow hematopoietic progenitor cells in vitro..  18:1094-1096. 1990
  • Assessment of purging with multidrug resistance (MDR) modulators and VP-16: results of long-term marrow culture..  18:940-944. 1990
  • Neonatal W-mutant mice are favorable hosts for tracking development of marked hematopoietic stem cells..  17:872-876. 1989
  • PROTO-ONCOGENE C-MYB IS EXPRESSED IN NORMAL HUMAN HEMATOPOIETIC PROGENITOR CELLS.  16:507-507. 1988
  • Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens..  15:239-242. 1987
  • Cooperative effects of gamma interferon and 1-alpha,25-dihydroxyvitamin D3 in inducing differentiation of human promyelocytic leukemia (HL-60) cells..  14:138-142. 1986
  • Aberrant interaction of B-cell lymphocytic leukemia cells with antibody coated polyacrylamide beads..  11:162-168. 1983
  • Evaluation of monolayer, liquid, gelfoam sponge and artificial capillary culture systems for the study of hematopoiesis..  9:187-196. 1981
  • Autologous marrow transplantation for patients with acute myelogenous leukemia--a preliminary report..  7 Suppl 5:302-308. 1979
  • Immunologic chimerism as evidence of bone marrow graft acceptance in an identical twin with acute lymphocytic leukemia..  3:244-248. 1975
  • Human acute leukemia cells with membrane-bound immunoglobulin..  2:259-263. 1974
  • IRGM1 IS A NEGATIVE REGULATOR OF INTERFERON SIGNALING AND AUTOPHAGY IN THE HEMATOPOIETIC STEM CELL 2010
  • Telomere length of donor cord blood cells predicts survival following a cord blood transplant 2006
  • Rapid in vivo acquisition of effector Tc1 phenotype before myeloid engraftment predicts opportunistic infections (OI) in cord blood transplant recipients 2005
  • A novel approach for expansion and activation of natural killer cell subsets in previously cryopreserved cord blood (CB) with anti-CD3, IL-2, IL-7 and IL-12: Implication for adoptive cellular immunotherapy post cord blood transplantation (CBT) 2004
  • Cord blood (CB) hematopoietic progenitor cell (HPC) characterization and correlation with ethnicity: A report from the COBLT/NHLBI program 2004
  • Unrelated cord blood (CB) banking, immune lymphocyte subsets and nucleated RBC characterization and correlation with ethnicity, birthweight, sex and type of delivery: A report from the COBLT/NHLBI program 2004
  • Ex vivo expansion of umbilical cord blood (UCB) derived immature and mature T cells for adoptive immunotherapy 2003
  • Inhibitory effect of a truncated form of c-MPL on TPO-dependent cell survival and proliferation 2003